Sugi Predict

Sugi Predict / Compounds / SCHEMBL25008329

SCHEMBL25008329

SCHEMBL25008329

c1ccc(-c2nc(-c3ccc4c(-c5cccc6ccccc56)cccc4c3)nc(-c3cccc4oc5ccccc5c34)n2)cc1

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ALDH1A1 P00352 9/20 0.45
▸ MAPT P10636 7/20 0.45
▸ HSD17B10 Q99714 6/20 0.45
▸ KDM4E B2RXH2 6/20 0.45
▸ HPGD P15428 6/20 0.45
▸ SMN1; SMN2 Q16637 3/20 0.45
▸ TDP1 Q9NUW8 2/20 0.45
▸ L3MBTL1 Q9Y468 2/20 0.45
▸ ATM Q13315 2/20 0.45
▸ MAPK1 P28482 2/20 0.45
▸ TSHR P16473 2/20 0.45
▸ TP53 P04637 1/20 0.45
▸ NFKB1 P19838 1/20 0.45
▸ NFKB2 Q00653 1/20 0.45
▸ RELA Q04206 1/20 0.45
▸ RAB9A P51151 3/20 0.37
▸ CYP1A2 P05177 2/20 0.37
▸ CYP2C19 P33261 1/20 0.37
▸ NPC1 O15118 1/20 0.36
▸ LMNA P02545 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29294109 0.97 ALDH1A1 (0.42) ALDH1A1MAPTHSD17B10KDM4EHPGD
SCHEMBL25008350 0.95 KDM4E (0.42) ALDH1A1MAPTHSD17B10KDM4EHPGD
SCHEMBL23820438 0.95 ALDH1A1 (0.42) ALDH1A1MAPTHSD17B10KDM4EHPGD
SCHEMBL24342490 0.95 ALDH1A1 (0.43) ALDH1A1MAPTHSD17B10KDM4EHPGD
SCHEMBL25008912 0.94 ALDH1A1 (0.42) ALDH1A1MAPTHSD17B10KDM4EHPGD
SCHEMBL25008346 0.94 KDM4E (0.41) ALDH1A1MAPTHSD17B10KDM4EHPGD
SCHEMBL25008997 0.94 ALDH1A1 (0.41) ALDH1A1MAPTHSD17B10KDM4EHPGD
SCHEMBL23759256 0.94 MAPT (0.41) ALDH1A1MAPTHSD17B10KDM4EHPGD
SCHEMBL24472886 0.94 MAPT (0.41) ALDH1A1MAPTHSD17B10KDM4EHPGD
SCHEMBL25008927 0.94 KDM4E (0.41) ALDH1A1MAPTHSD17B10KDM4EHPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4289836-A1 NOVEL COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE COMPRISING SAME Lg Chem, Ltd. (KR) 2023-12-13 — — EP disclosed
US-20230147959-A1 COMPOUND FOR ORGANIC OPTOELECTRONIC DEVICE, COMPOSITION FOR ORGANIC OPTOELECTRONIC DEVICE, ORGANIC OPTOELECTRONIC DEVICE AND DISPLAY DEVICE SAMSUNG SDI CO., LTD. (KR) 2023-05-11 — — US disclosed
US-20230147959-A1 COMPOUND FOR ORGANIC OPTOELECTRONIC DEVICE, COMPOSITION FOR ORGANIC OPTOELECTRONIC DEVICE, ORGANIC OPTOELECTRONIC DEVICE AND DISPLAY DEVICE SAMSUNG SDI CO., LTD. (KR) 2023-05-11 — — US disclosed
WO-2023014004-A1 NOVEL COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE COMPRISING SAME 주식회사 엘지화학 2023-02-09 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230147959-A1 COMPOUND FOR ORGANIC OPTOELECTRONIC DEVICE, COMPOSITION FOR ORGANIC OPTOELECTRONIC DEVICE, ORGANIC OPTOELECTRONIC DEVICE AND DISPLAY DEVICE OCIAD2, OCIAD1, OXER1 ALDH1A1 133/4885MAPT 958/4885HSD17B10 1528/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.